Kentaro Kogure Selected Research

Kentaro Kogure Research Topics

Disease

29	Neoplasms (Cancer) 01/2023 - 01/2002
9	Melanoma (Melanoma, Malignant) 01/2023 - 03/2003
6	Insulin Resistance 05/2014 - 01/2011
4	Fatty Liver 01/2022 - 01/2011
4	Inflammation (Inflammations) 10/2020 - 04/2009
3	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2024 - 10/2020
3	Leukemia 01/2021 - 05/2019
2	Ischemic Stroke 02/2022 - 01/2020
2	Reperfusion Injury 01/2022 - 01/2012
2	Brain Ischemia (Cerebral Ischemia) 01/2022 - 01/2020
2	Hyperplasia 06/2021 - 10/2020
2	Dry Eye Syndromes (Dry Eye Syndrome) 05/2020 - 01/2019
2	Stomach Ulcer (Gastric Ulcer) 01/2018 - 09/2016
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2014 - 11/2013
2	Non-alcoholic Fatty Liver Disease 01/2013 - 10/2012
2	Iron Overload 01/2013 - 01/2013
2	Carcinoma (Carcinomatosis) 03/2009 - 01/2002
1	Communicable Diseases (Infectious Diseases) 11/2023
1	Anaphylaxis (Anaphylactic Shock) 11/2023
1	Fever (Fevers) 11/2023
1	Sarcopenia 03/2023
1	Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked) 01/2023
1	Rare Diseases (Rare Disease) 01/2023
1	Liver Diseases (Liver Disease) 01/2023
1	Skin Diseases (Skin Disease) 01/2023
1	Colonic Neoplasms (Colon Cancer) 05/2022
1	Phobic Disorders (Phobia) 02/2022
1	Rheumatoid Arthritis 02/2022
1	Edema (Dropsy) 02/2022
1	Arthritis (Polyarthritis) 02/2022
1	Brain Injuries (Brain Injury) 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2021

Drug/Important Bio-Agent (IBA)

15	Liposomes (Liposome)IBA 01/2024 - 02/2007
9	Peptides (Polypeptides)IBA 03/2023 - 01/2010
8	Messenger RNA (mRNA)IBA 01/2024 - 12/2014
7	LipidsIBA 09/2022 - 11/2003
6	Succinic Acid (Succinate)IBA 01/2023 - 05/2004
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2013
5	Therapeutic UsesIBA 01/2024 - 08/2013
4	CytokinesIBA 01/2024 - 06/2021
3	Inosine Triphosphate (ITP)IBA 01/2024 - 01/2023
3	EstersIBA 01/2023 - 05/2004
3	Tocopherols (Tocopherol)IBA 01/2023 - 01/2020
3	AntioxidantsIBA 01/2023 - 01/2012
3	AntigensIBA 01/2023 - 04/2015
3	Membrane Proteins (Integral Membrane Proteins)IBA 02/2022 - 05/2019
3	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2022 - 05/2015
3	FructoseIBA 01/2013 - 10/2012
2	Tacrolimus (Prograf)FDA LinkGeneric 01/2024 - 01/2022
2	Imiquimod (Aldara)FDA LinkGeneric 01/2024 - 10/2020
2	mRNA VaccinesIBA 11/2023 - 01/2023
2	Lipid NanoparticlesIBA 11/2023 - 01/2022
2	CPG-oligonucleotideIBA 01/2023 - 03/2011
2	InterferonsIBA 01/2023 - 01/2023
2	Neuroprotective AgentsIBA 02/2022 - 01/2020
2	Small Interfering RNA (siRNA)IBA 01/2022 - 01/2017
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2021
2	AntibodiesIBA 09/2021 - 10/2020
2	OligodeoxyribonucleotidesIBA 06/2021 - 03/2011
2	AT1002IBA 06/2021 - 01/2017
2	Drug CarriersIBA 01/2021 - 01/2017
2	astaxanthine (astaxanthin)IBA 05/2020 - 01/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 12/2002
2	Indomethacin (Indometacin)FDA LinkGeneric 01/2018 - 09/2016
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2018 - 09/2016
2	ResistinIBA 05/2014 - 11/2013
2	IronIBA 01/2013 - 01/2013
2	Insulin (Novolin)FDA Link 01/2013 - 10/2012
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2013 - 10/2012
2	tamibaroteneIBA 01/2013 - 10/2012
2	Tuberculin (PPD)IBA 01/2010 - 10/2007
2	Matrix Metalloproteinases (MMPs)IBA 01/2010 - 10/2007
2	lysophosphatidic acidIBA 10/2002 - 01/2002
2	alkylglycerophosphoethanolamine phosphodiesteraseIBA 10/2002 - 01/2002
1	MyostatinIBA 03/2023
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2023
1	CytosineIBA 01/2023
1	CeramidesIBA 01/2023
1	VaccinesIBA 01/2023
1	GuanosineIBA 01/2023
1	Phosphates (Orthophosphate)IBA 01/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2022
1	Interleukin-10 (Interleukin 10)IBA 05/2022
1	laminaranIBA 02/2022
1	alpha-tocopherol phosphateIBA 02/2022
1	SolutionsIBA 02/2022
1	Connexin 43 (Connexin43)IBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 09/2021
1	Nucleic AcidsIBA 06/2021
1	hydroxide ionIBA 01/2021
1	Vitamin E FDA LinkGeneric 01/2021
1	Etanercept (Enbrel)FDA Link 10/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2020

Therapy/Procedure

10	Therapeutics 01/2023 - 02/2007
3	Immunotherapy 11/2023 - 03/2009
3	Intravenous Administration 10/2007 - 03/2003
2	Subcutaneous Injections 02/2022 - 10/2020
1	Intraperitoneal Injections 02/2022
1	Intravenous Injections 01/2022